Effects of synbiotic supplement on human gut microbiota, body composition and weight loss in obesity

Nutrients

Volumn 12, Issue 1, 2020, Pages

  Sergeev, Igor N ^a   Aljutaily, Thamer ^a   Walton, Gemma ^b   Huarte, Eduardo ^a  

^a SOUTH DAKOTA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF READING   (United Kingdom)

Author keywords

Body composition; Gut microbiota; Obesity; Obesity biomarkers; Prebiotic; Probiotic; Synbiotic; Weight loss

Indexed keywords

NUTRITION SUPPLEMENT; PLACEBO; RNA 16S; SYNBIOTIC AGENT;

ARTICLE; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM LONGUM; BIOINFORMATICS; BODY COMPOSITION; BODY MASS; BODY WEIGHT LOSS; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA EXTRACTION; FAT MASS; FECES ANALYSIS; FEMALE; FLUOROMETRY; GENE SEQUENCE; HIGH-PROTEIN LOW-CARBOHYDRATE DIET; HUMAN; INTESTINE FLORA; LACTOBACILLUS ACIDOPHILUS; MALE; METABOLIC PARAMETERS; MICROBIAL DIVERSITY; NONHUMAN; OBESITY; POLYMERASE CHAIN REACTION; POPULATION ABUNDANCE; SPECIES RICHNESS; SPECTROPHOTOMETRY; WAIST CIRCUMFERENCE; ADULT; BIFIDOBACTERIUM; DIETARY SUPPLEMENT; DRUG EFFECT; LACTOBACILLUS; LOW CALORIE DIET; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

ADULT; BIFIDOBACTERIUM; BODY COMPOSITION; DIET, REDUCING; DIETARY SUPPLEMENTS; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; LACTOBACILLUS; MALE; MIDDLE AGED; OBESITY; SYNBIOTICS; WEIGHT LOSS;

EID: 85078030701     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu12010222     Document Type: Article

References (55)

1. 2+ link to obesity and diabetes. J. Steroid Biochem. Mol. Biol. 2016, 164, 326–330.
2. Bouter, K.E.; van Raalte, D.H.; Groen, A.K.; Nieuwdorp, M. Role of the gut microbiome in the pathogenesis of obesity and obesity‐related metabolic dysfunction. Gastroenterology 2017, 152, 1671–1678.
3. Dao, M.C.; Clement, K. Gut microbiota and obesity: Concepts relevant to clinical care. Eur. J. Intern. Med. 2018, 48, 18–24, doi:10.1016/j.ejim.2017.10.005.
4. Isolauri, E. Microbiota and Obesity. Nestle Nutr. Inst. Workshop Ser. 2017, 88, 95–105, doi:10.1159/000455217.
5. Rowland, I.; Gibson, G.; Heinken, A.; Scott, K.; Swann, J.; Thiele, I.; Tuohy, K. Gut microbiota functions: Metabolism of nutrients and other food components. Eur. J. Nutr. 2018, 57, 1–24, doi:10.1007/s00394‐017‐1445‐8.
6. Boulange, C.L.; Neves, A.L.; Chilloux, J.; Nicholson, J.K.; Dumas, M.E. Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med. 2016, 8, 42, doi:10.1186/s13073‐016‐0303‐2.
7. Brahe, L.K.; Astrup, A.; Larsen, L.H. Can We Prevent Obesity‐Related Metabolic Diseases by Dietary Modulation of the Gut Microbiota? Adv. Nutr. 2016, 7, 90–101, doi:10.3945/an.115.010587.
8. Heiss, C.N.; Olofsson, L.E. Gut Microbiota‐Dependent Modulation of Energy Metabolism. J. Innate Immun. 2018, 10, 163–171, doi:10.1159/000481519.
9. Russell, W.R.; Gratz, S.W.; Duncan, S.H.; Holtrop, G.; Ince, J.; Scobbie, L.; Duncan, G.; Johnstone, A.M.; Lobley, G.E.; Wallace, R.J.; et al. High‐protein, reduced‐carbohydrate weight‐loss diets promote metabolite profiles likely to be detrimental to colonic health. Am. J. Clin. Nutr. 2011, 93, 1062–1072, doi:10.3945/ajcn.110.002188.
10. Brinkworth, G.D.; Noakes, M.; Clifton, P.M.; Bird, A.R. Comparative effects of very low‐carbohydrate, high‐fat and high‐carbohydrate, low‐fat weight‐loss diets on bowel habit and faecal short‐chain fatty acids and bacterial populations. Br. J. Nutr. 2009, 101, 1493–1502, doi:10.1017/S0007114508094658.
11. Duncan, S.H.; Belenguer, A.; Holtrop, G.; Johnstone, A.M.; Flint, H.J.; Lobley, G.E. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate‐producing bacteria in feces. Appl. Environ. Microbiol. 2007, 73, 1073–1078, doi:10.1128/AEM.02340‐06.
12. Blachier, F.; Beaumont, M.; Portune, K.J.; Steuer, N.; Lan, A.; Audebert, M.; Khodorova, N.; Andriamihaja, M.; Airinei, G.; Benamouzig, R.; et al. High‐protein diets for weight management: Interactions with the intestinal microbiota and consequences for gut health. A position paper by the my new gut study group. Clin. Nutr. 2018, 38, 1012–1022, doi:10.1016/j.clnu.2018.09.016.
13. Singh, R.K.; Chang, H.W.; Yan, D.; Lee, K.M.; Ucmak, D.; Wong, K.; Abrouk, M.; Farahnik, B.; Nakamura, M.; Zhu, T.H.; et al. Influence of diet on the gut microbiome and implications for human health. J. Transl. Med. 2017, 15, 73, doi:10.1186/s12967‐017‐1175‐y.
14. Lopez‐Legarrea, P.; Fuller, N.R.; Zulet, M.A.; Martinez, J.A.; Caterson, I.D. The influence of Mediterranean, carbohydrate and high protein diets on gut microbiota composition in the treatment of obesity and associated inflammatory state. Asia Pac. J. Clin. Nutr. 2014, 23, 360–368, doi:10.6133/apjcn.2014.23.3.16.
15. Yao, C.K.; Muir, J.G.; Gibson, P.R. Review article: Insights into colonic protein fermentation, its modulation and potential health implications. Aliment. Pharmacol. Ther. 2016, 43, 181–196, doi:10.1111/apt.13456.
16. Al Hinai, E.A.; Kullamethee, P.; Rowland, I.R.; Swann, J.; Walton, G.E.; Commane, D.M. Modelling the role of microbial p‐cresol in colorectal genotoxicity. Gut Microbes 2019, 10, 398–411.
17. Monda, V.; Villano, I.; Messina, A.; Valenzano, A.; Esposito, T.; Moscatelli, F.; Viggiano, A.; Cibelli, G.; Chieffi, S.; Monda, M.; et al. Exercise Modifies the Gut Microbiota with Positive Health Effects. Oxid. Med. Cell. Longev. 2017, 2017, 3831972, doi:10.1155/2017/3831972.
18. Han, M.; Wang, C.; Liu, P.; Li, D.; Li, Y.; Ma, X. Dietary Fiber Gap and Host Gut Microbiota. Protein Pept. Lett. 2017, 24, 388–396, doi:10.2174/0929866524666170220113312.
19. Anhe, F.F.; Varin, T.V.; Le Barz, M.; Desjardins, Y.; Levy, E.; Roy, D.; Marette, A. Gut Microbiota Dysbiosis in Obesity‐Linked Metabolic Diseases and Prebiotic Potential of Polyphenol‐Rich Extracts. Curr. Obes. Rep. 2015, 4, 389–400, doi:10.1007/s13679‐015‐0172‐9.
20. Martinez, K.B.; Leone, V.; Chang, E.B. Western diets, gut dysbiosis, and metabolic diseases: Are they linked? Gut Microbes 2017, 8, 130–142, doi:10.1080/19490976.2016.1270811.
21. Million, M.; Angelakis, E.; Paul, M.; Armougom, F.; Leibovici, L.; Raoult, D. Comparative meta‐analysis of the effect of Lactobacillus species on weight gain in humans and animals. Microb. Pathog. 2012, 53, 100– 108, doi:10.1016/j.micpath.2012.05.007.
22. Dardmeh, F.; Nielsen, H.I.; Alipour, H.; Kjaergaard, B.; Brandsborg, E.; Gazerani, P. Potential Nociceptive Regulatory Effect of Probiotic Lactobacillus rhamnosus PB01 (DSM 14870) on Mechanical Sensitivity in Diet‐Induced Obesity Model. Pain Res. Manag. 2016, 2016, 5080438, doi:10.1155/2016/5080438.
23. Esmaeilinezhad, Z.; Babajafari, S.; Sohrabi, Z.; Eskandari, M.‐H.; Amooee, S.; Barati‐Boldaji, R. Effect of synbiotic pomegranate juice on glycemic, sex hormone profile and anthropometric indices in PCOS: A randomized, triple blind, controlled trial. Nutr. Metab. Cardiovasc. Dis. 2019, 29, 201–208.
24. Suzumura, E.A.; Bersch‐Ferreira, Â.C.; Torreglosa, C.R.; da Silva, J.T.; Coqueiro, A.Y.; Kuntz, M.G.; Chrispim, P.P.; Weber, B.; Cavalcanti, A.B. Effects of oral supplementation with probiotics or synbiotics in overweight and obese adults: A systematic review and meta‐analyses of randomized trials. Nutr. Rev. 2019, 77, 430–450.
25. Vulevic, J.; Juric, A.; Tzortzis, G.; Gibson, G.R. A mixture of trans‐galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. J. Nutr. 2013, 143, 324–331.
26. McCormack, L.; Meendering, J.; Specker, B.; Binkley, T. Associations between sedentary time, physical activity, and dual‐energy X‐ray absorptiometry measures of total body, android, and gynoid fat mass in children. J. Clin. Densitom. 2016, 19, 368–374.
27. AlGhalith, G.A.; Montassier, E.; Ward, H.N.; Knights, D. NINJA‐OPS: Fast Accurate Marker Gene Alignment Using Concatenated Ribosomes. PLoS Comput. Biol. 2016, 12, e1004658, doi:10.1371/journal.pcbi.1004658.
28. Quast, C.; Pruesse, E.; Yilmaz, P.; Gerken, J.; Schweer, T.; Yarza, P.; Peplies, J.; Glockner, F.O. The SILVA ribosomal RNA gene database project: Improved data processing and web‐based tools. Nucleic Acids Res. 2013, 41, D590–D596, doi:10.1093/nar/gks1219.
29. Caporaso, J.G.; Kuczynski, J.; Stombaugh, J.; Bittinger, K.; Bushman, F.D.; Costello, E.K.; Fierer, N.; Pena, A.G.; Goodrich, J.K.; Gordon, J.I.; et al. QIIME allows analysis of high‐throughput community sequencing data. Nat Methods 2010, 7, 335–336, doi:10.1038/nmeth.f.303.
30. Lozupone, C.; Lladser, M.E.; Knights, D.; Stombaugh, J.; Knight, R. UniFrac: An effective distance metric for microbial community comparison. ISME J. 2011, 5, 169–172, doi:10.1038/ismej.2010.133.
31. Chiu, C.‐M.; Huang, W.‐C.; Weng, S.‐L.; Tseng, H.‐C.; Liang, C.; Wang, W.‐C.; Yang, T.; Yang, T.‐L.; Weng, C.‐T.; Chang, T.‐H.; et al. Systematic Analysis of the Association between Gut Flora and Obesity through High‐Throughput Sequencing and Bioinformatics Approaches. BioMed Res. Int. 2014, 2014, 906168, doi:10.1155/2014/906168.
32. De la Cuesta‐Zuluaga, J.; Mueller, N.T.; Corrales‐Agudelo, V.; Velásquez‐Mejía, E.P.; Carmona, J.A.; Abad, J.M.; Escobar, J.S. Metformin Is Associated With Higher Relative Abundance of Mucin‐Degrading Akkermansia muciniphila and Several Short‐Chain Fatty Acid–Producing Microbiota in the Gut. Diabetes Care 2016, 40, 54–62, doi:10.2337/dc16‐1324.
33. Wang, L.; Li, P.; Tang, Z.; Yan, X.; Feng, B. Structural modulation of the gut microbiota and the relationship with body weight: Compared evaluation of liraglutide and saxagliptin treatment. Sci. Rep. 2016, 6, 33251, doi:10.1038/srep33251.
34. Zarrati, M.; Salehi, E.; Nourijelyani, K.; Mofid, V.; Zadeh, M.J.; Najafi, F.; Ghaflati, Z.; Bidad, K.; Chamari, M.; Karimi, M.; et al. Effects of probiotic yogurt on fat distribution and gene expression of proinflammatory factors in peripheral blood mononuclear cells in overweight and obese people with or without weight‐loss diet. J. Am. Coll. Nutr. 2014, 33, 417–425, doi:10.1080/07315724.2013.874937.
35. Canfora, E.E.; van der Beek, C.M.; Hermes, G.D.A.; Goossens, G.H.; Jocken, J.W.E.; Holst, J.J.; van Eijk, H.M.; Venema, K.; Smidt, H.; Zoetendal, E.G.; et al. Supplementation of Diet With Galacto‐oligosaccharides Increases Bifidobacteria, but Not Insulin Sensitivity, in Obese Prediabetic Individuals. Gastroenterology 2017, 153, 87–97 e83, doi:10.1053/j.gastro.2017.03.051.
36. Azcarate-Peril, M.A.; Butz, N.; Cadenas, M.B.; Koci, M.; Ballou, A.; Mendoza, M.; Ali, R.; Hassan, H. An Attenuated Salmonella enterica Serovar Typhimurium Strain and Galacto‐Oligosaccharides Accelerate Clearance of Salmonella Infections in Poultry through Modifications to the Gut Microbiome. Appl. Environ. Microbiol. 2018, 84, doi:10.1128/AEM.02526‐17.
37. Ferrarese, R.; Ceresola, E.; Preti, A.; Canducci, F. Probiotics, prebiotics and synbiotics for weight loss and metabolic syndrome in the microbiome era. Eur. Rev. Med. Pharmacol. Sci. 2018, 22, 7588–7605.
38. Seganfredo, F.B.; Blume, C.A.; Moehlecke, M.; Giongo, A.; Casagrande, D.S.; Spolidoro, J.V.N.; Padoin, A.V.; Schaan, B.D.; Mottin, C.C. Weight‐loss interventions and gut microbiota changes in overweight and obese patients: A systematic review. Obes. Rev. 2017, 18, 832–851, doi:10.1111/obr.12541.
39. Aoki, R.; Kamikado, K.; Suda, W.; Takii, H.; Mikami, Y.; Suganuma, N.; Hattori, M.; Koga, Y. A proliferative probiotic Bifidobacterium strain in the gut ameliorates progression of metabolic disorders via microbiota modulation and acetate elevation. Sci. Rep. 2017, 7, 43522, doi:10.1038/srep43522.
40. Jiao, X.; Wang, Y.; Lin, Y.; Lang, Y.; Li, E.; Zhang, X.; Zhang, Q.; Feng, Y.; Meng, X.; Li, B. Blueberry polyphenols extract as a potential prebiotic with anti‐obesity effects on C57BL/6 J mice by modulating the gut microbiota. J. Nutr. Biochem. 2019, 64, 88–100, doi:10.1016/j.jnutbio.2018.07.008.
41. Hu, H.J.; Park, S.G.; Jang, H.B.; Choi, M.K.; Park, K.H.; Kang, J.H.; Park, S.I.; Lee, H.J.; Cho, S.H. Obesity Alters the Microbial Community Profile in Korean Adolescents. PLoS ONE 2015, 10, e0134333, doi:10.1371/journal.pone.0134333.
42. Brookheart, R.T.; Lewis, W.G.; Peipert, J.F.; Lewis, A.L.; Allsworth, J.E. Association between obesity and bacterial vaginosis as assessed by Nugent score. Am. J. Obstet. Gynecol. 2019, 220, doi:10.1016/j.ajog.2019.01.229.
43. Stanislawski, M.A.; Dabelea, D.; Lange, L.A.; Wagner, B.D.; Lozupone, C.A. Gut microbiota phenotypes of obesity. NPJ Biofilms Microbiomes 2019, 5, 18, doi:10.1038/s41522‐019‐0091‐8.
44. Ott, B.; Skurk, T.; Hastreiter, L.; Lagkouvardos, I.; Fischer, S.; Büttner, J.; Kellerer, T.; Clavel, T.; Rychlik, M.; Haller, D. Effect of caloric restriction on gut permeability, inflammation markers, and fecal microbiota in obese women. Sci. Rep. 2017, 7, 11955.
45. Diether, N.E.; Willing, B.P. Microbial Fermentation of Dietary Protein: An Important Factor in Diet—Microbe—Host Interaction. Microorganisms 2019, 7, 19, doi:10.3390/microorganisms7010019.
46. Louis, P.; Hold, G.L.; Flint, H.J. The gut microbiota, bacterial metabolites and colorectal cancer. Nat. Rev. Microbiol. 2014, 12, 661.
47. Dahiya, D.K.; Puniya, M.; Shandilya, U.K.; Dhewa, T.; Kumar, N.; Kumar, S.; Puniya, A.K.; Shukla, P. Gut Microbiota Modulation and Its Relationship with Obesity Using Prebiotic Fibers and Probiotics: A Review. Front. Microbiol. 2017, 8, 563, doi:10.3389/fmicb.2017.00563.
48. Million, M.; Maraninchi, M.; Henry, M.; Armougom, F.; Richet, H.; Carrieri, P.; Valero, R.; Raccah, D.; Vialettes, B.; Raoult, D. Obesity‐associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. Int. J. Obes. 2012, 36, 817–825, doi:10.1038/ijo.2011.153.
49. Gentile, C.L.; Weir, T.L. The gut microbiota at the intersection of diet and human health. Science 2018, 362, 776–780.
50. Cani, P.D. Targeting gut microbiota with a complex mix of dietary fibers improves metabolic diseases. Kidney Int. 2019, 95, 14–16.
51. Shetty, S.A.; Marathe, N.P.; Lanjekar, V.; Ranade, D.; Shouche, Y.S. Comparative genome analysis of Megasphaera sp. reveals niche specialization and its potential role in the human gut. PLoS ONE 2013, 8, e79353.
52. Korpela, K.; Flint, H.J.; Johnstone, A.M.; Lappi, J.; Poutanen, K.; Dewulf, E.; Delzenne, N.; de Vos, W.M.; Salonen, A. Gut microbiota signatures predict host and microbiota responses to dietary interventions in obese individuals. PLoS ONE 2014, 9, e90702, doi:10.1371/journal.pone.0090702.
53. Mirande, C.; Kadlecikova, E.; Matulova, M.; Capek, P.; Bernalier‐Donadille, A.; Forano, E.; Bera‐Maillet, C. Dietary fibre degradation and fermentation by two xylanolytic bacteria Bacteroides xylanisolvens XB1A and Roseburia intestinalis XB6B4 from the human intestine. J. Appl. Microbiol. 2010, 109, 451–460, doi:10.1111/j.1365‐2672.2010.04671.x.
54. Aljutaily, T.; Consuegra‐Fernandez, M.; Aranda, F.; Lozano, F.; Huarte, E. Gut microbiota metabolites for sweetening type I diabetes. Cell. Mol. Immunol. 2018, 15, 92–95, doi:10.1038/cmi.2017.65.
55. Rafter, J.; Bennett, M.; Caderni, G.; Clune, Y.; Hughes, R.; Karlsson, P.C.; Klinder, A.; O’Riordan, M.; O’Sullivan, G.C.; Pool‐Zobel, B. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am. J. Clin. Nutr. 2007, 85, 488–496.